BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 32472766)

  • 1. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.
    Maiese K
    Front Biosci (Landmark Ed); 2020 Jun; 25(11):1925-1973. PubMed ID: 32472766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
    Maiese K
    Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.
    Maiese K
    Int Rev Neurobiol; 2020; 155():1-35. PubMed ID: 32854851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
    Maiese K
    Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance.
    Benito-Cuesta I; Ordóñez-Gutiérrez L; Wandosell F
    Autophagy; 2021 Mar; 17(3):656-671. PubMed ID: 32075509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
    Maiese K
    Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte health: adapting to metabolic changes through autophagy.
    Kubli DA; Gustafsson AB
    Trends Endocrinol Metab; 2014 Mar; 25(3):156-64. PubMed ID: 24370004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System.
    Maiese K
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK and mTOR in cellular energy homeostasis and drug targets.
    Inoki K; Kim J; Guan KL
    Annu Rev Pharmacol Toxicol; 2012; 52():381-400. PubMed ID: 22017684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between AMPK and mTOR in regulating energy balance.
    Xu J; Ji J; Yan XH
    Crit Rev Food Sci Nutr; 2012; 52(5):373-81. PubMed ID: 22369257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis.
    Xiong Y; Yepuri G; Forbiteh M; Yu Y; Montani JP; Yang Z; Ming XF
    Autophagy; 2014; 10(12):2223-38. PubMed ID: 25484082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy: regulation by energy sensing.
    Meijer AJ; Codogno P
    Curr Biol; 2011 Mar; 21(6):R227-9. PubMed ID: 21419990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Maiese K
    Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocytes maintain high basal levels of autophagy independent of mtor signaling.
    Bork T; Liang W; Yamahara K; Lee P; Tian Z; Liu S; Schell C; Thedieck K; Hartleben B; Patel K; Tharaux PL; Lenoir O; Huber TB
    Autophagy; 2020 Nov; 16(11):1932-1948. PubMed ID: 31865844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking aim at Alzheimer's disease through the mammalian target of rapamycin.
    Maiese K
    Ann Med; 2014 Dec; 46(8):587-96. PubMed ID: 25105207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
    Maiese K
    Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Challenges and Strategies for Cardiac Disease: Autophagy, mTOR, and AMP-activated Protein Kinase.
    Maiese K
    Curr Neurovasc Res; 2020; 17(2):111-112. PubMed ID: 32036783
    [No Abstract]   [Full Text] [Related]  

  • 20. Asprosin promotes β-cell apoptosis by inhibiting the autophagy of β-cell via AMPK-mTOR pathway.
    Wang R; Hu W
    J Cell Physiol; 2021 Jan; 236(1):215-221. PubMed ID: 32557691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.